Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > John Demaree > Profile

John Demaree

Affiliations

  • Chief Commercial Officer at Karyopharm Therapeutics Inc. (KPTI), 2021-03-02
  • Chief Commercial Officer at G1 Therapeutics Inc. (GTHX), 2020-02-07
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
KPTI $14.54 7,500 $109,012.50 7,500 2020-08-26 Filing
GTHX $33.15 1,000 $33,151.10 5,250 2018-12-10 Filing